AG01DP2X

60325-46-4 | Sulprostone in 5mg/ml Methyl Acetate

Chemical structure of Sulprostone in 5mg/ml  Methyl Acetate, CAS 60325-46-4
AG01DP2X
sdsSDS
sdsCOA

Price

$0.00

WARNING This product is not for human or veterinary use.
Request For Quotation
CAS Number 60325-46-4
Catalog Number AG01DP2X(AGN-PC-0SVQFN)
Chemical Name Sulprostone in 5mg/ml Methyl Acetate
EC Number 262-173-0
IUPAC Name (Z)-7-[(1R,2R,3R)-3-hydroxy-2-[(E,3R)-3-hydroxy-4-phenoxybut-1-enyl]-5-oxocyclopentyl]-N-methylsulfonylhept-5-enamide
InChI InChI=1S/C23H31NO7S/c1-32(29,30)24-23(28)12-8-3-2-7-11-19-20(22(27)15-21(19)26)14-13-17(25)16-31-18-9-5-4-6-10-18/h2,4-7,9-10,13-14,17,19-20,22,25,27H,3,8,11-12,15-16H2,1H3,(H,24,28)/b7-2-,14-13+/t17-,19-,20-,22-/m1/s1
InChI Key UQZVCDCIMBLVNR-TWYODKAFSA-N
MDL Number MFCD00216056
Molecular Formula C23H31NO7S
Molecular Weight 465.5597
SMILES O=C1[C@H](C/C=CCCCC(NS(=O)(C)=O)=O)[C@@H](/C=C/[C@@H](O)COC2=CC=CC=C2)[C@H](O)C1
UNII 501Q5EQ1GM
Synonyms
16-phenoxy-omega-17,18,19,20-tetranor-PGE2 methylsulfonylamide, 16-phenoxytetranor-PGE2 methylsulfonylamide, 34.089 Pfizer, 5Z,13E-18R,11R,12R,15R- dihydroxy-9-oxo-16-phenoxy-17,18,19,20-tetranor- 5,13-prostadienoic acid methylsulfonylamide, CP-34089, Nalador, SHB 286, sulproston, sulprostone, ZK-57671, Sulprostone, Nalador, 60325-46-4, SHB 286, CP-34089, ZK-57671, Sulprostone [USAN:INN], Sulprostonum [INN-Latin], Sulprostona [INN-Spanish], UNII-501Q5EQ1GM, C23H31NO7S, EINECS 262-173-0, CP 34089, ZK 57671, 501Q5EQ1GM, sulproston, 16-Phenoxy-omega-17,18,19,20-tetranor pge-2 methylsulfonylamide, 16-Phenoxy-17,18,19,20 tetranor prostaglandin E(sub 2) methyl sulfonylamide, 16-Phenoxy-omega-17,18,19,20-tetranor prostaglandin E2 methylsulfonylamide, (Z)-7-((1R,2R,3R)-3-Hydroxy-2-((E)-(3R)-(3-hydroxy-4-phenoxy-1-butenyl))-5-oxocyclopentyl)-N-(methylsulfonyl)-5-heptenamide, Sulprostona, Sulprostonum, 5-Heptenamide, 7-(3-hydroxy-2-(3-hydroxy-4-phenoxy-1-butenyl)-5-oxocyclopentyl)-N-(methylsulfonyl)-, (1R-(1alpha(Z),2beta(1E,3R*),3alpha))-, 34.089 Pfizer, SHB-286, NCGC00165899-01, CP-34,089, ZK 57 671, 16-phenoxytetranor-PGE2 methylsulfonylamide, Sulprostone (USAN/INN), AC1NSM49, SCHEMBL94842, GTPL1919, CHEMBL1472830, CHEBI:135755, HMS3648J09, 16-phenoxy-omega-17,18,19,20-tetranor-PGE2 methylsulfonylamide, ZINC4474665, 2056AH, MFCD00216056, Sulprostone, >=95% (HPLC), oil, AKOS024457401, DB12708, 5-Heptenamide, 7-(3-hydroxy-2-(3-hydroxy-4-phenoxy-1-butenyl)-5-oxocyclopentyl)-N-(methylsulfonyl)-, (1R-(1a(Z),2b(1E,3R*),3a))-, 5Z,13E-18R,11R,12R,15R- dihydroxy-9-oxo-16-phenoxy-17,18,19,20-tetranor- 5,13-prostadienoic acid methylsulfonylamide, AN-39499, LS-74543, B7255, D02725, 325S464, SR-01000946436, SR-01000946436-1, BRD-K14551499-001-01-7, (5Z)-7-[(1R,2R,3R)-3-Hydroxy-2-[(1E,3R)-3-hydroxy-4-buten-1-yl]-5-oxocyclopentyl]-N-(methylsulfonyl)-5-heptenamide, (5Z,11alpha,13E,15R)--11,15-Dihydroxy-9-oxo-16-phenoxy-17,18,19,20-tetranorprosta-5,13-dienoic acid methane sulfonamide, (Z)-7-[(1R,2R,3R)-3-hydroxy-2-[(E,3R)-3-hydroxy-4-(phenoxy)but-1-enyl]-5-oxocyclopentyl]-N-methylsulfonylhept-5-enamide, (Z)-7-[(1R,2R,3R)-3-hydroxy-2-[(E,3R)-3-hydroxy-4-phenoxy-but-1-enyl]-5-oxo-cyclopentyl]-N-methylsulfonyl-hept-5-enamide, (Z)-7-[(1R,2R,3R)-3-hydroxy-2-[(E,3R)-3-hydroxy-4-phenoxybut-1-enyl]-5-oxocyclopentyl]-N-methylsulfonylhept-5-enamide, 5-Heptenamide, 7-(3-hydroxy-2-(3-hydroxy-4-phenoxy-1-butenyl)-5-oxocyclopentyl)-N-(methylsulfonyl)-, (1R-(1-alpha(Z),2-beta(1E,3R*),3-alpha))-, Nalador (TN), D0X2UE, C23-H31-N-O7-S, CID5312153, C016767, 5-Heptenamide, 7-[3-hydroxy-2-(3-hydroxy-4-phenoxy-1-butenyl)-5-oxocyclopentyl]-N-(methylsulfonyl)-, [1R-[1.alpha.(Z),2.beta.(1E,3R*),3.alpha.]]-,

Related Research Chemicals

CERTIFICATE OF ANALYSIS
Chemical Name: Batch Number:
Chemical Structure: CAS Registry No:
Product ID:
Manufacture Date:
Storage Temperature:
Formula:
Molecular Weight:
Quantity:
Analysis Data:
Test: Result:
Conclusion: The above product meets the specifications of Angene.
Analyst:Chase
Date:
Reviewed by:Jessie
Date:
Angene International Limited